Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 132 participants.
Also called NCT06949228
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 132 participants
- Sponsor
- ProMedica Health System
- Registry
-
NCT06949228
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06949228. Randomized; no masking; primary purpose treatment. Start 2025-07-30 (actual); primary completion 2028-05-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
- Acronym
- ALLY II TNK
- Condition
- Ischemic Stroke
- Condition
- Acute Disease
- Intervention (Drug)
- tenecteplase
- Lead sponsor
- ProMedica Health System
Record details
- Record id
cardio:ct-nct06949228- Content hash
82bc8ef356e9898fa226e66b7107a37b3b5145ba2ab38d92f40e53106b28523b